As many of these genes epigenetically targeted by the PI3K pathway may be oncogenetically important, their aberrant changes in expression, through alterations in their methylation by the PI3K pathway, are expectedly important tumor-promoting events. This evidence concerns the gene PIK3CA and neoplasm.